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A B S T R A C T   
Response inhibition has previously been suggested as an endophenotype for obsessive–compulsive disorder 
(OCD), evidenced by studies showing worse task performance, and altered task-related activation and connec-
tivity. However, it’s unclear if these measures change following treatment. In this study, 31 OCD patients and 28 
healthy controls performed a stop signal task during 3 T functional magnetic resonance imaging before treat-
ment, while 24 OCD patients and 17 healthy controls were rescanned one week and three months after 
concentrated exposure and response prevention over four consecutive days using Bergen 4-Day Format. To study 
changes over time we performed a longitudinal analysis on stop signal reaction time and task-related activation 
and amygdala connectivity during successful and failed inhibition. Results showed that there was no group 
difference in task performance. Before treatment, OCD patients compared to controls showed less inhibition- 
related activation in the right inferior frontal gyrus, and increased functional connectivity between the right 
amygdala and the right inferior frontal gyrus and pre-supplementary motor area. During error-processing, OCD 
patients versus controls showed less activation in the pre-SMA before treatment. These group differences did not 
change after treatment. Pre-treatment task performance, brain activation, and connectivity were unrelated to the 
degree of symptom improvement after treatment. In conclusion, inferior frontal gyrus hypoactivation and 
increased fronto-limbic connectivity are likely trait markers of OCD that remain after effective exposure therapy.   
1. Introduction 
Obsessive-compulsive disorder (OCD) is characterized by intrusive 
obsessions and repetitive compulsions (American Psychiatric Associa-
tion, 2013). The disorder affects 1–3% of the population, is related to 
substantial impairment in personal, family and work life, and often re-
mains chronic if untreated (Stein et al., 2019). 
OCD patients have difficulty stopping rituals or ruminating once they 
have started, and tasks measuring the ability to cancel behaviors may be 
relevant to study the neurobiological processes underlying these symp-
toms (van Velzen et al., 2014). Response inhibition involves suppressing 
and cancelling actions in order to efficiently complete a task. Different 
paradigms exist that assess the subprocesses of inhibition, ranging from 
interference control tasks (e.g. Flanker task), action withholding tasks 
(e.g. Go/No-go task), and action cancellation tasks (e.g. Stop signal task; 
SST) (van Velzen et al., 2014). Meta-analyses have shown that OCD 
patients show small to moderate difficulties in response inhibition 
relative to healthy controls, with the largest difference in action 
cancellation (Snyder et al., 2015). 
Functional neuroimaging studies have related OCD to subtle alter-
ations in cortico-striato-thalamo-cortical, fronto-parietal, and fronto- 
limbic circuits (Stein et al., 2019). A recent meta-analysis (Norman 
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et al., 2019) of response inhibition found that OCD patients compared to 
controls showed less inhibition-related activation in areas of the fronto- 
parietal and ventral attention networks, including the dorsal anterior 
cingulate cortex (dACC) and anterior insula. Hyperactivation was found 
in the premotor, orbitofrontal, parietal, and temporal cortices, as well as 
the thalamus and caudate nucleus. OCD patients also showed more 
error-related activation in cingulo-opercular regions, also including the 
dACC and pre-supplementary motor area (pre-SMA) (Norman et al., 
2019). 
In an endophenotype functional magnetic resonance imaging (fMRI) 
study of the SST in 41 OCD unmedicated patients, 17 unaffected siblings 
and 37 healthy controls, patients (compared to controls) showed less 
activation in the right IFG and inferior parietal during inhibition, while 
both patients and siblings (compared to controls) showed more pre-SMA 
activation. Pre-SMA activation was suggested to be compensatory since 
it was related to better inhibitory task performance (shorter stop-signal 
reaction time; SSRT) (de Wit et al., 2012). Patients and unaffected sib-
lings also showed less connectivity between the left IFG and bilateral 
amygdala during successful inhibition, which was negatively related to 
pre-SMA activation (van Velzen et al., 2015). This suggests that both 
OCD patients and siblings show altered recruitment of inferior frontal 
and premotor cortices during action cancellation, as well as altered 
limbic connectivity. 
Recommended first-line treatments for OCD include exposure and 
response prevention (ERP) and serotonin reuptake inhibitors (SRI) 
(Stein et al., 2019). ERP can be effectively delivered intensively, weekly, 
individually or in group-settings (Öst et al., 2015). Rapid and sustained 
recovery after concentrated treatment may be provide a basis for 
investigating both short- and long-term changes in task performance and 
inhibition-related brain network function. 
There are few studies on how response inhibition and its neural 
correlates change after successful treatment (Thorsen et al., 2015). 
Previous findings have been inconsistent, with both increased or un-
changed task-related activation (or event related potentials when using 
EEG) after treatment, and inconsistencies in where the changes were 
observed (Nabeyama et al., 2008; Nakao et al., 2005; Riesel et al., 2015). 
It’s therefore unclear if hyperactivation or hypoactivation are trait 
markers or endophenotypes of OCD, or if they are dependent on the 
severity of the disorder (de Wit et al., 2012). If these are traits, one 
would expect that these abnormalities remain after successful treatment. 
If they are state-related, hyperactivations might increase so that patients 
resemble unaffected siblings (de Wit et al., 2012), or decrease if 
compensation is no longer needed. There is also evidence that increased 
fronto-limbic connectivity may interfere with cognitive control in OCD 
and unaffected siblings (de Vries et al., 2014; van Velzen et al., 2015). 
We recently found reduced (normalized) connectivity between the 
fronto-parietal and limbic networks after treatment using resting-state 
fMRI (Thorsen et al., 2020), which may suggest that limbic and task- 
related areas become more independent after treatment. 
We here investigated if concentrated ERP leads to changes in per-
formance, task-related brain activation and connectivity during the 
response inhibition and error processing using the SST. Following a 
preregistered analysis plan (https://osf.io/ye7q3), we first assessed 31 
patients and 28 controls the day before treatment, and assessed changes 
in 24 patients and 17 healthy controls after one week and after three 
months. During successful inhibition, we expected to find hypo-
activation in the IFG, dACC and parietal cortex, hyperactivation of the 
pre-SMA, and increased fronto-limbic connectivity in OCD patients 
before treatment. We also expected more dACC and pre-SMA activation 
during error processing. After treatment, we expected increased 
inhibition-related activation in the pre-SMA, IFG, inferior parietal cor-
tex, and dACC, and the fronto-limbic connectivity to normalize. We did 
not expect error-related activation to decrease after treatment. 
2. Methods 
2.1. Participants 
The study recruited 35 OCD patients and 31 healthy controls before 
treatment (See Table 1 for demographics, comorbidity, and medication). 
Patients were recruited from a specialized outpatient OCD clinic at 
Haukeland University Hospital, Bergen, Norway, while controls were 
recruited using bulletin boards, social media, and emails to local busi-
nesses. Patients were 18 years or older, had a primary diagnosis of OCD, 
had a minimum Yale Brown Obsessive Compulsive Scale (Y-BOCS) 
(Goodman et al., 1989) score of 16, and were fluent in Norwegian. 
Exclusion criteria for patients were symptoms primarily associated with 
hoarding, ongoing substance abuse, bipolar disorder or psychosis, sui-
cidal ideation, intellectual disability, or being unwilling to refrain from 
benzodiazepines or alcohol during treatment. Participants were 
required to be MRI compatible and not have a neurological illness. After 
exclusions, the baseline sample consisted of 31 OCD patients and 28 
healthy controls, while 24 patients and 17 controls were included in 
longitudinal analyses including the day before treatment, after one week 
(directly after treatment), and after three months (See Supplemental 
Fig. 1 for a flowchart with reasons for exclusions). The study was 
approved by the Regional Ethics Committee for South-Eastern Norway 
(2015/936) and all participants provided informed written consent. 
2.2. Measures 
All participants were diagnosed using the Structured Clinical Inter-
view (SCID) for DSM-IV (First et al., 2002), and healthy controls were 
free of any current or lifetime disorders. The Y-BOCS (Goodman et al., 
1989), Patient Health Questionnaire (PHQ-9) (Kroenke et al., 2001), and 
Generalized Anxiety Disorder (GAD-7) (Spitzer et al., 2006) were used to 
measure severity of obsessive–compulsive, depressive, and anxiety 
symptoms. Clinical remission was defined as a total Y-BOCS score under 
13 and response as a minimum of 35% reduction on the Y-BOCS (Mataix- 
Cols et al., 2016). The Behavior Rating Inventory of Executive Function 
(BRIEF) (Roth et al., 2013) was used to measure subjective problems in 
Table 1 




26)    
M (SD) M (SD) t p 
Age 30.19 
(9.21) 
31 (10.73) 0.31 0.76 




0.25 0.81  
n (%) n (%) χ2 P 
Female 19 (61) 18 (64) 0.06 1 
Handedness (right) 29 (94) 26 (93) 0.01 1 
On medication 7 (23) – – – 
SSRI 6 (19) – – – 
Methylphenidate 1 (3) – – – 
Childhood onset of OCD 14 (45) – – – 
Major Depressive Disorder 9 (29) – – – 
Generalized Anxiety Disorder 9 (29) – – – 
Social Anxiety Disorder 7 (23) – – – 
Specific Phobia 4 (13) – – – 
Panic disorder with/without 
agoraphobia 
3 (10) – – – 
Hypochondriasis 3 (10) – – – 
Dysthymia 2 (7) – – – 
Post-Traumatic Stress Disorder 1 (3) – – – 
Attention Deficit Hyperactivity 
Disorder 
1 (3) – – – 
Somatization disorder 1 (3) – – – 
Pain disorder 1 (3) – – – 
Abbreviations: HC, healthy controls; OCD, obsessive–compulsive disorder; SSRI, 
selective serotonin reuptake inhibitors. 
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executive function in OCD patients and through informant reports from 
family members before treatment. 
2.3. Bergen 4-Day treatment 
The Bergen 4-Day Treatment (B4DT) format is delivered during four 
consecutive days in groups for 3–6 patients with a 1:1 ratio between 
patients and therapists (Havnen et al., 2014; 2017;; Launes et al., 2019; 
Riise et al., 2016, 2018). Routine clinical data and a randomized control 
trial have found a remission rate of 75%, while an additional 10% were 
improved, and 15% showed no significant change one week after 
treatment (Havnen et al., 2014, 2017; Launes et al., 2019), which are 
largely maintained after four years (Hansen et al., 2019). The first day of 
the B4DT consists of a group session with psychoeducation and planning 
of individual exposure tasks. The next two days consist of therapist- 
assisted exposure with response prevention in relevant settings. Pa-
tients are also instructed to perform exposure between the second and 
fourth day. The last day consists of relapse prevention and planning of 
self-exposure for the next three weeks (Kvale et al., 2018). 
2.4. Stop signal task 
The SST (de Wit et al., 2012) required responding to the direction of 
an arrow (left or right) by pressing a button with the index finger of the 
concordant hand during go-trials (Supplemental Fig. 2). Participants 
were instructed to respond as quickly and accurately as possible. Go- 
trials were pseudo-randomly mixed with stop-trials where participants 
are instructed to withhold their response when a cross was overlaid on 
the arrow with a variable delay. The delay of the stop signal was 
continuously adapted by a staircase tracking mechanism, so that the 
participant reaches around 50% accuracy on stop-trials. Stop signal re-
action time (SSRT) was calculated using the integration method over 
four blocks (Verbruggen et al., 2013). Exclusion criteria were go-trial 
error percentage over 40% or failed stop-trials outside of the 25–75% 
range (Congdon et al., 2012). Group differences in performance was 
tested using t-tests and repeated-measures ANOVAs (RM-ANOVA) 
including the two groups over the three time points. 
2.5. Image acquisition and analyses 
MRI was done on a 3 T General Electric Discovery MR750 with an 
eight-channel head coil at Haukeland university hospital, Bergen, Nor-
way. An anatomical T1-weighted image was recorded in a 256 × 256 
matrix, 192 slices, voxel size approximately isotropic 1 mm3, TE = 30 
ms, TR = 7000 s, flip angle = 12◦, FoV = 256 mm. We acquired 430 echo 
planar images using a 64x64 matrix, 34 slices (2.8 mm thickness with 
0.2 mm gap), TR = 2100 ms, TE = 30 ms, flip angle = 80◦, FoV = 22 mm, 
voxel size = 3.44 × 3.44 × 3 mm, interleaved slice excitation. Functional 
data were preprocessed in SPM12 using slice time correction, realign-
ment, coregistering anatomical and functional images, normalization to 
MNI using unified segmentation, reslicing voxels to 3 mm3, and 8 mm 
smoothing with a FWHM kernel. Participants with movement exceeding 
one voxel were excluded. Accurate go-trials, accurate stop-trials, failed 
stop-trials were then modeled as 0 s events in subject-level models, along 
with six motion parameters. A high pass filter with 128 s cut-off was then 
applied to remove low frequency noise. 
We used the generalized psychophysiological interaction toolbox 
(gPPI) (McLaren et al., 2012) to model task-related functional connec-
tivity during accurate go-trials, accurate stop-trials, failed stop-trials. 
The left (MNI -23,-2,-16) and right amygdala (MNI 23,0,-16) were 
defined as spherical 5 mm seed regions based on the Anatomical La-
beling Atlas as previous studies have found aberrant amygdala con-
nectivity during tasks probing action cancellation and working memory 
in OCD patients and their unaffected siblings (de Vries et al., 2014; van 
Velzen et al., 2015). PPI models included the three task regressors, three 
PPI regressors, time course of the seed region, and six motion 
parameters. 
Group comparisons for both activation and connectivity were done 
by entering successful response inhibition (SucStop > SucGo) and failed 
inhibition (FailStop > SucStop) into separate second-level models. We 
used permutation-based statistics for imaging analyses, as they are less 
dependent on statistical assumptions (Winkler et al., 2014). The Statis-
tical Nonparametric Mapping (SnPM) toolbox (http://nisox. 
org/Software/SnPM13/) was used for baseline t-tests, and the Multi-
variate and Repeated Measures (MRM) toolbox (McFarquhar et al., 
2016) for RM-ANOVAs. 
We defined regions of interest (ROI) based on the findings of a recent 
meta-analysis of the SST (Cieslik et al., 2015). To ensure optimal 
placement we first investigated the effect of successful and failed inhi-
bition across the whole sample at baseline (N = 59, voxel-wise pFWE <
0.05), and then placed 10 mm spheres in the bilateral anterior insula/ 
IFG, pre-SMA, operculum, inferior parietal cortex, and midline posterior 
cingulate cortex for successful inhibition (Table 2 and Supplemental 
Results). We excluded two healthy controls due to signal loss in the IFG. 
We did not find an effect of inhibition in the thalamus, dACC or sub-
thalamic nucleus and these ROIs were therefore excluded. For failed 
inhibition we defined the midline dACC and pre-SMA (Table 2 and 
Supplemental Results). ROIs were combined into two separate binary 
masks for successful and failed inhibition, respectively. ROI analyses 
were performed by limiting the included voxels to the binary mask, 
which provided a single volume correction including all ROIs. Statistical 
significance was set at voxel-wise pFWE < 0.05. Exploratory analyses at 
uncorrected p < .001 are also presented for comparisons with previous 
studies. Results of whole-brain analyses at an uncorrected threshold are 
presented in the Supplement. 
3. Results 
3.1. Demographics, symptoms, and executive problems 
OCD patients and healthy controls were matched on age, gender and, 
educational status (Table 1). OCD patients showed significant im-
provements over time on the Y-BOCS (F(2, 46) = 112.07, p < .001) and 
GAD-7 (F(2, 36) = 12.71, p < .001), but not PHQ-9 (F(2, 34) = 1.37, p =
.27). Healthy controls showed no significant changes in GAD-7 or PHQ-9 
over time (Table 3). One week after treatment, 16 (67%) patients were 
in remission, six (25%) significantly improved, and two (8%) were un-
changed. After three months, 19 (79%) were in remission, two (8%) 
significantly improved, and three (13%) unchanged. Based on the 
BRIEF, OCD patients reported worse problems in most executive do-
mains than the normal population, particularly in task shifting and 
initiation. This was also supported by informant reports from the family 
of the patient (Supplemental Table 1). 
Table 2 
Regions of interest for successful and failed inhibition (defined as 10 mm spheres 
around peak).  
Region Hemisphere MNI coordinates (X, Y, Z) 
Successful inhibition (SucStop > SucGo) 
Anterior insula/IFG L –33, 23, 5 
Anterior insula/IFG R 35, 23, − 11 
Pre-SMA L − 6, 11, 50 
Pre-SMA R 3, 20, 53 
Operculum L − 42, 5, 29 
Operculum R 44, 10, 29 
Inferior parietal cortex L − 55, − 46, 35 
Inferior parietal cortex R 55, − 46, 21 
Posterior cingulate cortex Midline 2, − 24, 32 
Failed inhibition (FailStop > SucStop) 
Dorsal ACC Midline 0, 21, 34 
Pre-SMA Midline 0, 11, 62 
Abbreviations: ACC, anterior cingulate cortex; IFG, inferior frontal gyrus; MNI, 
Montreal Neurological Institute; pre-SMA, pre-supplementary motor area. 
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3.2. Task performance 
There were no significant group differences in SSRT or go-trial re-
action time at any time point (Table 4). The RM-ANOVA of SSRT showed 
no significant effects of group (F(1, 41) = 0.59, p = .44), time (F(1,82) =
0.06, p = .81), and group × time interaction (F(2,82) = 1.03, p = .36). 
3.3. Task-related brain activation 
During successful inhibition, OCD patients (n = 31) showed less 
activation than healthy controls (n = 26) in the right IFG before treat-
ment (Table 5, Fig. 1). This right IFG hypoactivation in OCD patients was 
not found in the RM-ANOVA, which showed no significant effects of 
group, time or group × time interaction (OCD n = 24 versus HC n = 17). 
Right IFG hypoactivation in OCD patients before treatment was also 
evident in whole-brain analyses at an uncorrected threshold (Supple-
mental Table 6). 
During error processing, OCD patients (n = 24) showed less pre-SMA 
activation than healthy controls (n = 26) (MNI 0,14,62, t = 2.98, pFWE =
0.05) before treatment. The RM-ANOVA showed no significant effects of 
group, time or group × time interaction (OCD n = 24 versus HC n = 17). 
Pre-SMA hypoactivation in OCD patients was not significant in explor-
atory whole-brain analysis (Supplemental Table 7). 
3.4. Task-related connectivity 
Before treatment, OCD patients (n = 31) compared to controls (n =
26) showed significantly more connectivity between the right amygdala 
and pre-SMA during successful inhibition, while more connectivity with 
the right IFG reached a trend level (Table 6). Right amygdala-pre-SMA 
hyperconnectivity was also found at a corrected threshold in whole- 
brain analysis (Supplemental Table 8). There were no significant 
group differences for left amygdala connectivity in ROI analyses, but 
some findings emerged in exploratory whole-brain analyses (Supple-
mental Table 9). To investigate the group differences over time for the 
right amygdala we ran a 2x3 RM-ANOVA (24 OCD versus 17 HC over 
three time points), which revealed a significant effect of group in the 
right pre-SMA, with no significant effects of time or group × time 
interaction (Table 7, Fig. 1). This was also evident in whole-brain 
analysis at an uncorrected threshold (Supplemental Table 12). Within- 
group analyses of extracted beta values found that OCD patients 
showed increased positive connectivity between the right amygdala and 
the right IFG for successful inhibition versus go-trials (t(30) = 2.37, p =
.02), while healthy controls showed no significant difference between 
task conditions (t(25) = -1.78, p = .09, Fig. 2). For connectivity between 
amygdala and pre-SMA, 2x3 RM-ANOVAs (successful stop- versus suc-
cessful go over three time points) found that OCD patients showed 
increased connectivity during successful inhibition versus go-trials (F 
(1,23) = 9.89, p < .01, η2p = .30). In comparison, healthy controls 
showed decreased connectivity during successful inhibition versus go- 
trials (F(1,16) = 6.68, p = .02, η2p = .29). 
On the failed inhibition contrast, there were no group differences in 
connectivity with the left or right amygdala before treatment. RM- 
ANOVAs also found no significant group, time, or group × time inter-
action effects. 
3.5. Correlations of task performance and imaging with behavioral and 
clinical measures 
We used MarsBar to extract the mean estimate of IFG activation, 
amygdala-pre-SMA, and amygdala-IFG connectivity using 6 mm spheres 
around the peak voxel. Peak voxels for pre-treatment IFG activation and 
amygdala-IFG connectivity was defined as the voxel with the highest t- 
value in the t-test comparing OCD patients and healthy controls (Ta-
bles 5 and 6), while the peak voxel for amygdala-pre-SMA connectivity 
was defined as the voxel with the highest F-value in the effect of group in 
the repeated-measures ANOVA (Table 7). Exploratory tests in IBM SPSS 
Statistics 25 were then used to assess the relationship between these 
variables and symptom severity or task performance. Using Pearson 
correlations we found no significant relations between pre-treatment 
activation or connectivity and pre-treatment Y-BOCS, GAD-7 or PHQ-9 
severity. A multilevel regression analysis including all time points 
found that more right amygdala-IFG connectivity during successful in-
hibition was related to longer SSRT in OCD patients (b = 7.39, SE =
3.45, t = 2.14, p = .037), which was not found for right amygdala-pre- 
SMA connectivity. Linear regression models were used to investigate if 
pre-treatment SSRT, IFG activation, amygdala-pre-SMA, or amygdala- 
IFG connectivity predicted Y-BOCS severity after treatment while 
adjusting for baseline Y-BOCS severity, but these models did not result in 
any significant findings. Finally, two-sample t-tests suggested that 
medication use, age of onset, or comorbid anxiety or mood disorders 
were not significantly related to IFG activation, amygdala-pre-SMA, or 
amygdala-IFG connectivity in OCD patients (Supplementary Figs. 5–8). 
4. Discussion 
We compared OCD patients and healthy controls on task perfor-
mance, task-related brain activation, and connectivity during response 
inhibition and error processing, and studied how these measures 
changed after effective behavioral treatment. As hypothesized, OCD 
patients compared to controls showed less right IFG activation during 
successful response inhibition before treatment, but there were no 
Table 3 
Symptom scores over time in OCD patients (n = 24) and healthy controls (n =
17).  






Y-BOCS OCD 26.83 (4.26) 10.33 (5.58) 10.33 (6.37) 
GAD-7 OCD 12.46 (5.33) 8.41 (4.23) 7.10 (4.52) 
HC 2.16 (2.63) 1.89 (2.05) 2.00 (2.17) 
PHQ-9 OCD 11.08 (5.83) 8.73 (6.10) 8.32 (5.49) 
HC 2.53 (1.71) 2.32 (1.83) 2.11 (1.53) 
Abbreviations: GAD-7, Generalized Anxiety Disorder 7; HC, healthy controls; 
OCD, obsessive–compulsive disorder; PHQ-9, Patient Health Questionnaire 9; Y- 
BOCS, Yale-Brown Obsessive Compulsive Scale. 
Table 4 
Task performance inhibition between OCD (n = 24) and HC (n = 19) over time.   
Before treatmentM (SD)  After one weekM (SD)  After three monthsM (SD)  
OCD HC t p  OCD HC t p  OCD HC t p 



























1.36  0.18 
Errors on go- 
trials (%) 
0.02 (0.01) 0.01 (0.02)  0.37  0.71  0.02 (0.02) 0.02 (0.02)  0.37  0.52  0.02 (0.03) 0.03 (0.04)  1.46  0.15 
Abbreviations: HC, healthy controls; OCD, obsessive–compulsive disorder; RT, response time. 
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significant changes over time. During successful inhibition, patients also 
showed more connectivity between the right amygdala and the pre-SMA 
across time, and with right IFG before treatment, whereas healthy 
controls showed no significant difference in connectivity between go- 
and stop-trials. We did not observe a difference in task performance 
between patients and controls before or after treatment, but exploratory 
findings suggested that IFG-amygdala connectivity correlated positively 
with SSRT in patients across time. Contrary to our hypotheses, patients 
showed no significant changes in IFG activation or fronto-limbic con-
nectivity after treatment, suggesting that these are stable vulnerability 
Table 5 
Group differences in activation during inhibition between OCD (n = 31) and HC (n = 26) before treatment.  
Region Side BA Voxels X Y Z T pFWE pUnc Direction 
IFG R 47 3 42 20 − 16  3.76  0.023  0.001 HC > OCD 
Abbreviations: HC, healthy controls; IFG, inferior frontal gyrus; OCD, obsessive–compulsive disorder; R, right. 
Fig. 1. Right IFG activation and connectivity between the right amygdala and right pre-SMA during successful inhibition in OCD patients (n = 24) and healthy 
controls (n = 17). Legend Fig. 1: Panel A depicts the voxels in the right inferior frontal gyrus (IFG) where OCD patients showed less activation than healthy controls 
during successful inhibition compared to successful go-trials. B shows activation parameter estimates in the right IFG during successful inhibition compared to 
successful go-trials for each group and timepoint, as well as individual data points. Panel C depicts the voxels in the pre-SMA where OCD patients and healthy 
controls showed significant differences in right amygdala connectivity during successful inhibition versus successful go-trials D shows condition-specific connectivity 
estimates between the right amygdala and right pre-SMA during successful stop and go-trials. Healthy controls show a non-significant tendency towards stronger 
connectivity between the right pre-SMA and right amygdala during successful go-trials, while OCD patients show significantly stronger connectivity between the two 
regions during successful inhibition before treatment and three months after treatment. * indicates a significant group difference at p < .05 based on parameter 
estimates extracted using 6 mm spheres, with error bars representing one standard error. 
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markers of OCD that are unrelated to treatment outcome. 
Norman and colleagues (Norman et al., 2019) have suggested that 
key regions for inhibitory control are underrecruited in OCD, leading to 
worse inhibitory control. They further propose that patients are aware of 
this underperformance, leading to an increased error response. In turn, 
this leads to greater limbic involvement and even poorer inhibitory 
control (Norman et al., 2019). The present findings of less task-related 
IFG activation and more fronto-limbic connectivity partially support 
these hypotheses. However, we did not see worse task performance 
during inhibition nor more activation during error processing. Norman 
and colleagues (Norman et al., 2019) only found a very small difference 
in response time between OCD patients and healthy controls suggesting 
that very large samples are needed to reliably detect this behavioral 
difference. Further, a combined EEG-fMRI study found that OCD pa-
tients compared with healthy controls can show stronger error-related 
negativity without a significant difference in pre-SMA BOLD ampli-
tude (Grutzmann et al., 2016). 
The finding of IFG hypoactivation in OCD patients versus healthy 
controls replicates the finding of our earlier cross-sectional study using 
this same stop-signal paradigm in a different sample, scanner, and 
country (de Wit et al., 2012). It is also in line with structural studies 
showed altered volume of this region in OCD (de Wit et al., 2014) and a 
negative association between IFG volume and inhibitory performance 
(Menzies et al., 2007). Hypoactivation of the IFG in OCD patients could 
be related to subtle alterations in attention to the stop-signal, response 
selection or inhibitory impairment, since the IFG plays an integral role in 
these processes (Aron et al., 2014). Although we did not observe any 
differences in task performance at the group-level, we did find that 
increased connectivity between the right amygdala and right IFG during 
successful inhibition was related to longer SSRT in OCD, suggestive of 
limbic interference on inhibitory control (de Vries et al., 2014; van 
Velzen et al., 2015). 
The increased amygdala-pre-SMA connectivity during successful 
inhibition versus go-trials in patients may be indicative of increased 
salience of the stop-signal in general, possibly due to an oddball phe-
nomenon (Dayan-Riva et al., 2019). Interestingly, fronto-limbic con-
nectivity in the same sample of OCD patients was reduced after 
treatment when measured at rest (Thorsen et al., 2020). This suggests 
that limbic interference may be modulated by increased task demands 
(de Vries et al., 2014). Future work could use tasks with varying task 
loads and emotional stimuli to better understand if abnormal task per-
formance or network activation are a result of altered cognitive capacity, 
emotional interference, or inflexibility (Bradbury et al., 2011; Thorsen 
et al., 2018). 
Contrary to our previous reports, we did not replicate findings of 
increased pre-SMA activation (de Wit et al., 2012) or increased 
Table 6 
Group differences in amygdala connectivity during inhibition between OCD (n = 31) and HC (n = 26) before treatment.  
Seed region Region Side BA Voxels X Y Z T pFWE pUnc Direction 
R amygdala Pre-SMA Midline 8 14 0 26 59  5.21  0.001  <0.001 OCD > HC 
R amygdala IFG R 47 10 33 26 − 16  3.46  0.071  <0.001 OCD > HC 
Abbreviations: HC, healthy controls; IFG, inferior frontal gyrus; OCD, obsessive–compulsive disorder; Pre-SMA, pre-supplementary motor area; R, right. 
Table 7 
Effect of group for amygdala connectivity during inhibition between OCD (n = 24) and HC (n = 17) over time.  
Seed region Region Side BA Voxels X Y Z F pFWE pUnc Direction 
R amygdala Pre-SMA R 8 2 3 23 56  17.73  0.042  <0.001 OCD > HC 
Abbreviations: HC, healthy controls; OCD, obsessive–compulsive disorder; Pre-SMA, pre-supplementary motor area; R, right. 
Fig. 2. Task-related connectivity between the right 
amygdala and right pre-SMA during successful inhi-
bition in OCD patients (n = 24) and healthy controls 
(n = 17). Psychophysiological interaction for con-
nectivity between the right amygdala and right pre- 
SMA during successful stop and go-trials. Healthy 
controls show no significant changes in connectivity 
between the successful inhibition and successful go- 
trials, while OCD patients show significantly stron-
ger more positive connectivity during successful in-
hibition than successful go-trials before treatment and 
three months after treatment. * indicates a significant 
group difference at p < .05 based on parameter esti-
mates extracted using 6 mm spheres, with error bars 
representing one standard error.   
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connectivity between the left IFG and the amygdala in patients versus 
controls (van Velzen et al., 2015). These null findings could be influ-
enced by sample size and sample characteristics. Moreover, we here 
observed more positive fronto-limbic connectivity during successful 
inhibition in OCD compared to controls, whereas we previously found 
increased negative connectivity during inhibition, but positive connec-
tivity during working memory (de Vries et al., 2014). We cannot exclude 
the possibility that differences in direction of fronto-limbic connectivity 
alterations are related to methodological differences in PPI analyses. 
Less pre-SMA activation during failed inhibition versus successful stop 
trials in OCD patients compared to healthy controls before treatment 
was also an unexpected finding. A recent meta-analysis found that OCD 
patients on average showed more pre-SMA activation during error 
processing than healthy controls (Norman et al., 2019), but this was not 
found in either of the two included studies using the SST (de Wit et al., 
2012; Rubia et al., 2010). It is unclear if the correlates of error pro-
cessing differ by the kind of response inhibition. The SST specifically 
measures action cancellation, as the stop signal is presented after the 
presentation of the go-signal (van Velzen et al., 2014). Action cancel-
lation may be a more difficult form of response inhibition and may be 
particularly relevant for OCD as these patients show difficulties in 
stopping compulsions that have already been initiated (van Velzen et al., 
2014). Parametric studies of working memory and planning have sug-
gested that OCD patients are unable to maintain the required increases 
in activation during more difficult trials when compared to healthy 
controls (de Vries et al., 2014; Heinzel et al., 2018; van den Heuvel et al., 
2005). It is therefore possible that OCD patients are similarly unable to 
maintain pre-SMA activation during error processing in the more diffi-
cult SST than other response inhibition tasks. 
This study is limited by the sample size. Thus, most findings from ROI 
analyses were only significant at an uncorrected threshold in whole- 
brain analyses. The limited sample size also precluded equivalence 
tests to formally determine that activation and connectivity estimates 
were equal over time in OCD patients. A wait-list control condition may 
also have formally excluded the possibility of non-specific variation over 
time. 
This is the first study to show that IFG activation and fronto-limbic 
connectivity during response inhibition in OCD does not change after 
concentrated ERP. Furthermore, we found no evidence that pre- 
treatment IFG activation or fronto-limbic connectivity predicted treat-
ment outcome. The present findings extend previous evidence that both 
OCD patients and unaffected siblings (de Wit et al., 2012; van Velzen 
et al., 2015), compared to unrelated healthy controls, show abnormal 
IFG activation and fronto-limbic connectivity during response inhibi-
tion. Together with the lack of change over time as presented in this 
study, this suggests that these are trait markers of OCD. 
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Launes, G., Hagen, K., Sunde, T., Öst, L.-G., Klovning, I., Himle, J., Kvale, G., 2019. 
A randomized controlled trial of concentrated ERP for obsessive-compulsive 
disorder: The Bergen 4-day treatment. Front. Psychol. 10, 2500. https://doi.org/ 
10.3389/fpsyg.2019.02500. 
Mataix-Cols, D., Fernandez de la Cruz, L., Nordsletten, A.E., Lenhard, F., Isomura, K., 
Simpson, H.B., 2016. Towards an international expert consensus for defining 
treatment response, remission, recovery and relapse in obsessive-compulsive 
disorder. World Psychiatry 15 (1), 80–81. https://doi.org/10.1002/wps.20299. 
McFarquhar, M., McKie, S., Emsley, R., Suckling, J., Elliott, R., Williams, S., 2016. 
Multivariate and repeated measures (MRM): A new toolbox for dependent and 
multimodal group-level neuroimaging data. Neuroimage 132, 373–389. https://doi. 
org/10.1016/j.neuroimage.2016.02.053. 
McLaren, D.G., Ries, M.L., Xu, G., Johnson, S.C., 2012. A generalized form of context- 
dependent psychophysiological interactions (gPPI): a comparison to standard 
approaches. Neuroimage 61 (4), 1277–1286. https://doi.org/10.1016/j. 
neuroimage.2012.03.068. 
Menzies, L., Achard, S., Chamberlain, S.R., Fineberg, N., Chen, C.H., del Campo, N., 
Bullmore, E., 2007. Neurocognitive endophenotypes of obsessive-compulsive 
disorder. Brain 130 (Pt 12), 3223–3236. https://doi.org/10.1093/brain/awm205. 
Nabeyama, M., Nakagawa, A., Yoshiura, T., Nakao, T., Nakatani, E., Togao, O., Kanba, S., 
2008. Functional MRI study of brain activation alterations in patients with obsessive- 
compulsive disorder after symptom improvement. Psychiatry Res. 163 (3), 236–247. 
https://doi.org/10.1016/j.pscychresns.2007.11.001. 
Nakao, T., Nakagawa, A., Yoshiura, T., Nakatani, E., Nabeyama, M., Yoshizato, C., 
Kanba, S., 2005. Brain activation of patients with obsessive-compulsive disorder 
during neuropsychological and symptom provocation tasks before and after 
symptom improvement: a functional magnetic resonance imaging study. Biol. 
Psychiatry 57 (8), 901–910. https://doi.org/10.1016/j.biopsych.2004.12.039. 
Norman, L.J., Taylor, S.F., Liu, Y., Radua, J., Chye, Y., De Wit, S.J., Fitzgerald, K., 2019. 
Error processing and inhibitory control in obsessive-compulsive disorder: a meta- 
analysis using statistical parametric maps. Biol. Psychiatry 85 (9), 713–725. https:// 
doi.org/10.1016/j.biopsych.2018.11.010. 
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